Volume II
June 2008
The Massachusetts life sciences “Super cluster” continues to change the face of medicine by driving research innovation, but it faces increasing competition for talent and funding from other states and countries, according to the 2008 Massachusetts Life Sciences Super cluster report, released today by PricewaterhouseCoopers, the New England Healthcare Institute, the Massachusetts Life Sciences Center, Xconomy and the Massachusetts Technology Collaborative.
Massachusetts has a high concentration of life sciences assets in close proximity, including academic medical centers, researchers, entrepreneurs, venture capitalists, and biotechnology, medical device and pharmaceutical companies. While the report highlights the region’s strength, it also says there are signs that industry and government may need to work harder to protect the state’s pipeline of innovation and ensure Massachusetts' long-term success in life sciences. The report also raised some concerns about whether Massachusetts companies will be able to continue to mine its strengths in research and commercialize the ideas coming out of the state’s laboratories.
The 2008 report includes the personal perspectives of a number of industry leaders in the state and findings from a survey of 147 industry executives from Massachusetts life sciences organizations. The report also raised some concerns about whether Massachusetts companies will be able to continue to mine its strengths in research and commercialize the ideas coming out of the state’s laboratories.
Publications Search Page
